Archives
Pazopanib in ATRX-Deficient Tumor Research
2026-08-27
Pazopanib (GW-786034) offers a mechanistically rich way to study how angiogenic and proliferative receptor tyrosine kinase signaling intersects with ATRX-deficient tumor biology. This thought-leadership guide translates evidence from high-grade glioma research into practical experimental design, biomarker strategy, and translational decision-making.
Stiripentol: LDH Inhibition in Metabolic Assays
2026-08-26
Stiripentol is a research-ready LDH inhibitor for connecting lactate metabolism with neuronal excitability, histone lactylation, and immune-cell function. This workflow explains how to prepare, dose, and interpret Stiripentol experiments while separating established epilepsy evidence from emerging immunometabolic applications.
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-26
Build a practical far-red detection workflow for rabbit primary antibodies across immunofluorescence, western blotting, IHC, ICC, and flow cytometry. This guide connects assay design and troubleshooting to ASB3–MAVS antiviral signaling, with actionable starting conditions for stronger, cleaner fluorescence data.
CH 223191: Practical AhR Antagonist Workflows
2026-08-26
CH 223191 helps researchers separate aryl hydrocarbon receptor signaling from broader chemical stress in ovarian, hepatic, and environmental toxicology models. This guide translates a mouse follicle study into practical dosing, readout, troubleshooting, and assay-design decisions.
LGK-974 PORCN Inhibitor Workflows
2026-08-25
Build reproducible Wnt secretion assays, pathway readouts, and disease-model experiments with LGK-974, a potent PORCN inhibitor. This workflow connects developmental Wnt-patterning insights with practical studies of pancreatic cancer RNF43 mutation models and other Wnt-dependent systems.
ABT-888 (Veliparib) for DNA Repair Workflows
2026-08-24
ABT-888 (Veliparib) enables controlled PARP1/2 inhibition for DNA repair inhibition, chemotherapy and radiation sensitization, and resistance studies. This practical guide connects colorectal cancer research and MSI tumor models with a newer biomarker-led strategy from high-grade serous ovarian cancer research.
BIRB 796 Workflows for p38α MAPK Research
2026-08-24
Build more interpretable p38α experiments with BIRB 796 (Doramapimod), from cytokine production inhibition and phospho-Western blots to apoptosis assays. This workflow combines selective allosteric inhibition with a recent dephosphorylation-focused model, helping researchers distinguish pathway suppression from changes in phospho-protein turnover.
ARCA Cy5 EGFP mRNA: Assay Guide
2026-08-23
ARCA Cy5 EGFP mRNA (5-moUTP) is a fluorescently labeled, 5-methoxyuridine modified mRNA for measuring delivery and EGFP expression in mammalian cells. Its paired Cy5 and EGFP readouts help separate intracellular cargo detection from translation, while the product record specifies a 996-nucleotide transcript supplied at 1 mg/mL.
ATRX Deficiency and RTK Inhibitor Sensitivity in Glioma
2026-08-22
The reference study identifies ATRX deficiency as a context associated with increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination results with temozolomide support ATRX-aware interpretation of targeted-treatment studies, while also emphasizing the need for validation in models that better reproduce tumor biology and drug exposure.
Topotecan in Recurrent Small Cell Lung Cancer
2026-08-21
This review established intravenous topotecan as a clinically useful option for recurrent small cell lung cancer (SCLC), including both chemosensitive and refractory relapse. Its key contribution was to connect efficacy, symptom palliation, dosing flexibility, and manageable hematologic toxicity in a treatment setting where prognosis and therapeutic choices were limited.
Caspase-3–NDUFS1 Signaling in Trichothecene Liver Injury
2026-08-20
This preprint identifies a caspase-3–NDUFS1 pathway that links trichothecene exposure to mitochondrial complex I disruption and amplified ROS production, while also implicating ER-localized ERO1α as a separate oxidative source. Its integrated mitochondrial–ER model helps explain hepatotoxicity mechanistically and suggests a framework for combining ROS, apoptosis, and membrane-potential measurements.
S-Adenosylhomocysteine in Neural Assays
2026-08-20
Use S-Adenosylhomocysteine to impose defined methyltransferase inhibition and test how SAM/SAH ratio modulation influences radiation-associated neural phenotypes. This workflow connects metabolic control with neurite outgrowth, neuronal marker expression, and pathway-focused validation while emphasizing careful dose, stability, and rescue controls.
Sex Differences in Angiotensin II Hypertension in Mice
2026-08-19
Xue, Pamidimukkala, and Hay used telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces substantially greater hypertension in male than female conscious mice. The study links this divergence to sex-dependent hormonal and autonomic mechanisms, providing a rigorous framework for interpreting cardiovascular experiments beyond resting blood pressure alone.
AZD2461: Reliable PARP Inhibitor Assays
2026-08-19
Learn how AZD2461 (SKU A4164) can support more interpretable viability, proliferation, and cytotoxicity experiments in breast cancer models. This scenario-based guide connects PARP biology with solvent handling, exposure design, endpoint selection, and vendor reliability.
Sulfamonomethoxine Workflows for Veterinary Research
2026-08-18
Sulfamonomethoxine (SMM) supports controlled susceptibility, veterinary microbiology, aquaculture, and environmental transformation studies without conflating laboratory activity with clinical dosing. This guide translates a veterinary staphylococcal testing strategy into practical assay design, stock preparation, comparative analysis, and troubleshooting.
588 records 9/40 page Previous Next First page 上5页 678910 下5页 Last page